Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury

NCT06548802 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Injury After Intracerebral Hemorrhage

Interventions

DRUG: Baricitinib

Sponsor

Tianjin Medical University General Hospital

Collaborators

[object Object]